Skip to main content

Advertisement

Table 2 Mean reticulocyte counts during the administration of CERA by Q2W and Q4W

From: Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients

CERA dosage (μg/4 weeks) Q2W/1000 (cells/μL) Q4W/1000 (cells/μL) p value
50 (N = 25) 40.7 ± 10.0 36.2 ± 9.9 <0.005
100 (N = 13) 41.6 ± 12.5 35.8 ± 7.8 <0.05
150 (N = 6) 44.7 ± 10.8 38.4 ± 7.0 <0.05
All (N = 44) 41.5 ± 10.7 36.4 ± 8.8 <0.0001
  1. Variables are represented as mean ± standard deviation